ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Mannkind Corporation clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 66 studies whose lead sponsor is Mannkind Corporation or the company grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 14, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Compare Mannkind with Novo Nordisk and Eli Lilly →

Pipeline: 4 programs

Each counted once: 4 with a study Mannkind Corporation leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 4 (approved, new studies)

The 4 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Mannkind Corporation’s own registered studies; Mannkind Corporation’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Mannkind Corporation’s studies test, most open studies first — 12 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 2 more

Coming up

1 of Mannkind Corporation’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 66 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now35%
  • Completed5482%
  • Stopped early812%
  • Status unknown or other12%

Phase

  • Phase 126
  • Phase 220
  • Phase 317
  • Phase 43

Where

  • United States47
  • Russian Federation10
  • Brazil8
  • Canada8
  • United Kingdom7
  • Ukraine6

Over the years

  1. 07
  2. 1008
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 17 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Mannkind Corporation.

  • Mannkind Corporation
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    57 studies
  • scPharmaceuticals, Inc.
    Acquired — became part of Mannkind Corporation, Oct 7, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    9 studies →

Focus areas

Conditions Mannkind Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 66. Browse all 66 →